Charles River Laboratories International (CRL) Gains from Sales and Divestitures (2011)
Charles River Laboratories International (CRL) recorded quarterly Gains from Sales and Divestitures of $295457.0 in Q3 2011, up 1.2% quarter-over-quarter from $291942.0 in Q2 2011.
Charles River Laboratories International (CRL) Gains from Sales and Divestitures (2011) Analysis & Trends
Charles River Laboratories International's Gains from Sales and Divestitures history runs 1 years deep, the most recent figure standing at $295457.0 for Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Charles River Laboratories International | 9.23 Bn | 9.02 Bn | 744.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 24, 2011 | 295,457.00 |
| Sep 24, 2011 | 295,457.00 |
| Jun 25, 2011 | 291,942.00 |
| Jun 25, 2011 | 291,942.00 |